pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    LMN-201
    Clostridioides difficile Infections (Clostridium difficil… Lumen Bioscience Inc
  • Phase 1
    LP-102
    Clostridioides difficile Infections (Clostridium difficil… Lpoxy Therapeutics Inc
  • Phase 2
    LXE-408
    Leishmaniasis$NVS NOVARTIS AG
  • pre_registration
← prev
page 10 of 24
next →
Pain89
Neurology1
Lagevrio
Lagevrio (molnupiravir)
Coronavirus Disease 2019 (COVID-19)
$MRK Merck & Co., Inc.
  • Marketed
    Lopimune
    Lopinavir + Ritonavir ((lopinavir + ritonavir))
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Cipla USA Inc
  • Preclinical
    MBP-091
    Marburgvirus Infections (Marburg Hemorrhagic Fever) Mapp Biopharmaceutical Inc
  • Phase 1
    MBP-134
    Ebolavirus Infections (Ebola Hemorrhagic Fever) Mapp Biopharmaceutical Inc
  • Phase 1
    MDX-2301
    Coronavirus Disease 2019 (COVID-19) ModeX Therapeutics Inc
  • Phase 2
    MGD-014
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$MGNX MACROGENICS INC
  • Phase 3
    MK-1406
    Pandemic Influenza$MRK Merck & Co., Inc.
  • Phase 2
    MP-1032
    Coronavirus Disease 2019 (COVID-19) MetrioPharm AG
  • Phase 1
    MRX-8
    Acinetobacter Infections MicuRx Pharmaceuticals Inc
  • Phase 2
    MVAmBN-396
    Eastern Equine Encephalitis Bavarian Nordic AS
  • Phase 2
    MVCCOV-1901
    Coronavirus Disease 2019 (COVID-19) Medigen Vaccine Biologics Corp
  • Preclinical
    Marburg vaccine
    Marburgvirus Infections (Marburg Hemorrhagic Fever)$SNGX SOLIGENIX, INC.
  • Phase 1
    NAS-150
    Idiopathic Pulmonary Fibrosis New Amsterdam Sciences Inc
  • Preclinical
    NGoXIM
    NGoXIM
    Gonorrhea TherapyX Inc
  • Phase 3
    NP-028
    Coronavirus Disease 2019 (COVID-19)$EBS Emergent BioSolutions Inc.
  • Phase 2
    NP-213
    Novexatin
    Onychomycosis (Tinea Unguium) Novabiotics Ltd
  • Phase 2
    NTCDM-3
    Clostridioides difficile Infections (Clostridium difficil… Destiny Pharma Ltd
  • Preclinical
    NV-360
    Herpes Zoster (Shingles)$NNVC NANOVIRICIDES, INC.
  • Preclinical
    NVK-006
    Unspecified Infectious Diseases Nevakar Injectables Inc
  • Marketed
    Nizoral
    Ketoconazole Patriot (ketoconazole)
    Pityriasis Simplex Capillitii (Dandruff) Patriot Pharmaceuticals LLC
  • Phase 2
    Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
    Norovirus Infections$VXRT Vaxart, Inc.
  • Phase 1
    OCF-001
    Vulvovaginal Candidiasis Sano Chemicals Inc
  • Preclinical
    OCU-510
    Seasonal Influenza$OCGN Ocugen, Inc.
  • Preclinical
    OCU-520
    Coronavirus Disease 2019 (COVID-19)$OCGN Ocugen, Inc.
  • Preclinical
    OS-151
    Tuberculosis OncoSTING LLC
  • Preclinical
    Oximo
    Genital Herpes Oxymo Technologies Inc
  • Preclinical
    P-MAPA
    Schistosomiasis Farmabrasilis